Company: AEMD
Filing Date: 2025-08-29
Form Type: S-1/A
Source: 0001683168-25-006537
Chunk: 73

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-29
Form: S-1/A
Chunk 73
---
 into a securities
purchase agreement directly with certain institutional investors, at such investor’s option, which purchase our securities in this
offering. Investors that do not enter into a securities purchase agreement shall rely solely on this prospectus in connection with the
purchase of our securities in this offering. There is no minimum number of securities or amount of proceeds that is a condition to closing
of this offering.

| 42 |

Fees and Expenses

The following table shows the
per share and accompanying warrant and per pre-funded warrant and accompanying warrant and
total placement agent fees we will pay in connection with the sale of the securities in this offering.

|                      |     | Per Share and        
 Accompanying Warrant |     | Per Pre-Funded Warrant and Accompanying Warrant |
|:---------------------|:----|:---------------------|:----|:------------------------------------------------|
| Placement Agent Fees |     | $                    |     | $                                               |
| Total                |     | $                    |     | $                                               |

We have agreed to pay the placement
agent a cash fee equal to 6.25% of the gross proceeds raised at the closing of this offering. We also agreed to issue warrants
to the placement agent for the purchase of a number of shares of common stock equal to 4% of the total number of shares of common stock
issued in this offering. In addition, we have agreed to reimburse the placement agent for its legal fees and expenses and other out-of-pocket
expenses in an amount up to $100,000. We estimate the total offering expenses of this offering that will be payable by us, excluding
the placement agent fees and expenses, will be approximately $ .

Placement Agent Warrants

In
addition, we have agreed to issue to the placement agent or its designees warrants to purchase up to 182,648 shares of common
stock (which represents 4% of the aggregate number of shares of common stock issued in this offering) with an exercise price of $2.19
per share (representing 100% of the combined public offering price per share of common stock (or pre-funded warrant) and accompanying
warrant in this offering). The placement agent warrants will be non-exercisable for six (6) months after the date of the closing and
will expire five years after the commencement of sales of the offering. The form of the placement agent warrants has been included as
an exhibit to this registration statement of which this prospectus is a part.

Lock-up Agreements